Trial Profile
Dose Escalating and Randomized, Placebo-Controlled, Double-Blind Study to Assess Safaty, Immunogenicity, and Protective Efficacy of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites (PfSPZ Vaccine) in Healthy African Adults in Mali
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Apr 2021
Price :
$35
*
At a glance
- Drugs Malaria vaccine live attenuated-Sanaria (Primary) ; AP-HSA; Artemether/lumefantrine; Artemisinin; Artesunate/amodiaquine
- Indications Falciparum malaria
- Focus Adverse reactions
- 10 Jul 2018 Status changed from recruiting to completed.
- 07 Mar 2018 Planned End Date changed from 28 Feb 2018 to 31 Aug 2018.
- 07 Mar 2018 Planned primary completion date changed from 28 Feb 2018 to 31 Aug 2018.